|
A CD47-blocking oncolytic vaccinia virus for cancer therapy
|
5F30CA203270-03
|
$44,524
|
CAO, FELICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
A differentiation-based mechanism limiting pancreatic tumor initiation
|
5F30CA192819-04
|
$49,524
|
KRAH, NATHAN
|
UNIVERSITY OF UTAH
|
|
A Paradigm Shift in Chronic Lymphocytic Leukemia: Defining the Role of Hematopoietic Stem Cells in Leukemogenesis
|
1F30CA225070-01A1
|
$38,725
|
HU, EILEEN
|
OHIO STATE UNIVERSITY
|
|
A Potent and Specific Approach to Targeting B-Cell Lymphoma: Disrupting Malignant Protein-Protein Interactions Using CD19-Targeted Stapled Peptide Amphiphile Nanoparticles
|
5F30CA221250-02
|
$49,524
|
SCHNORENBERG, MATHEW
|
UNIVERSITY OF CHICAGO
|
|
A Systems Biology Approach to Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
|
5F30CA213737-02
|
$44,724
|
MCGEHEE, CORDELIA
|
MAYO CLINIC ROCHESTER
|
|
Alternative End-Joining in DNA Repair and Chromosomal Translocations
|
5F30CA189740-05
|
$49,524
|
KUMAR, VIPUL
|
HARVARD MEDICAL SCHOOL
|
|
Alternative Splicing of Amyloid Precursor-Like Protein 2 during the Epithelial-Mesenchymal Transition and Cancer Metastasis
|
5F30CA196118-04
|
$38,851
|
HARVEY, SAMUEL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
AMPK Regulation of Microtubule Dynamics in Breast Cancer Metastasis
|
5F30CA196075-04
|
$37,843
|
CHAKRABARTI, KRISTI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
An Automated, Optical Imaging Platform for Early Detection of Oral Neoplasia
|
5F30CA213922-02
|
$49,524
|
YANG, ERIC
|
RICE UNIVERSITY
|
|
Analysis of the novel phenomenon of antibody-mediated fratricide in Acute Myeloid Leukemia
|
5F30CA217006-02
|
$49,524
|
FATEHCHAND, KAVIN
|
OHIO STATE UNIVERSITY
|
|
ATR: a novel therapeutic target for medulloblastoma identified by its role in cerebellar development
|
5F30CA192832-04
|
$41,614
|
LANG, PATRICK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
B7x in Cancer: Mechanisms and Therapies
|
1F30CA224931-01
|
$49,524
|
JOHN, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Balancing Efficacy and Toxicity of Intratumoral Reolysin for Diffuse Intrinsic Pontine Glioma (DIPG)
|
5F30CA210334-03
|
$44,724
|
SCHUELKE, MATTHEW
|
MAYO CLINIC ROCHESTER
|
|
Bile Acid-Mediated IQGAP1 Regulation Drives Hepatic Tumorigenesis
|
1F30CA206495-01A1
|
$45,271
|
ERICKSON, HANNA
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
BORG: Role for a Novel lncRNA in Mediating Breast Cancer Metastasis and Dormancy
|
5F30CA203233-03
|
$49,524
|
GOODING, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
BRAF splice variants in RAF inhibitor resistant melanoma
|
5F30CA203314-03
|
$45,713
|
VIDO, MICHAEL
|
THOMAS JEFFERSON UNIVERSITY
|
|
Cell-Mediated Immunity Following Listeria monocytogenes Induced Inflammasome Activation
|
5F30CA210912-03
|
$24,310
|
THEISEN, ERIN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Characterization of a novel RNA-guided endoRNAse and applications towards genome-wide screening for non-coding RNA roles in melanoma resistance
|
5F30CA210382-02
|
$49,524
|
ABUDAYYEH, OMAR
|
HARVARD MEDICAL SCHOOL
|
|
Characterization of growth factor control of Argonaute 2 and RAS interaction
|
5F30CA221011-02
|
$36,163
|
SIEBENALER, RONALD
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Characterizing HBEGF in glioma formation and maintenance
|
5F30CA203096-03
|
$32,385
|
SHIN, CLIFFORD
|
UNIVERSITY OF UTAH
|
|
Characterizing the mechanical maturation of the centromere in human cells in the context of aneuploidy and cancer
|
5F30CA223591-02
|
$45,745
|
JELENCHICK, LAUREN
|
UNIVERSITY OF MINNESOTA
|
|
Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies
|
5F30CA203292-04
|
$49,524
|
SWAROOP, ALOK
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Clinical bacterial isolate engineered as an immunotherapy for prostate cancer
|
5F30CA203472-03
|
$49,524
|
ANKER, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
CN/NFAT Signaling in Fibroblast Activation and Metastasis
|
5F30CA196079-03
|
$31,426
|
LIEBERMAN, ALLYSON
|
UNIVERSITY OF PENNSYLVANIA
|
|
Co-Evolution of the CD8+ T Cell Repertoire and AML In the Setting of Immunotherapy
|
5F30CA213878-02
|
$49,524
|
GEORGE, JASON
|
RICE UNIVERSITY
|
|
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance
|
5F30CA220847-02
|
$49,524
|
ALI, MOIEZ
|
DUKE UNIVERSITY
|
|
Combination FGFR4 and ER-Targeted Therapy for Invasive Lobular Carcinoma
|
5F30CA203154-02
|
$45,339
|
LEVINE, KEVIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Contributions of sympathetic signals to prostate cancer progression.
|
5F30CA203446-03
|
$49,524
|
ZAHALKA, ALI
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
CXCR3 in Pancreatic Cancer Progression and Metastasis
|
1F30CA225117-01
|
$33,026
|
CANNON, ANDREW
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Cytokine induced RelB/p50 complexes drive mesenchymal glioma progression
|
5F30CA200252-03
|
$36,044
|
WATERS, MICHAEL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Cytokine-induced RelB phosphorylation in glioblastoma multiforme
|
5F30CA203447-03
|
$36,044
|
GUPTA, ANGELA
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Defining and translating the properties that sustain the antitumor efficacy of Th17 cells
|
5F30CA200272-04
|
$46,154
|
BOWERS, JACOB
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Defining novel drivers and predictive signatures of metastasis in osteosarcoma th
|
5F30CA186633-05
|
$49,524
|
MORROW, JAMES
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining Novel Mechanisms of Genome Instability in BRAF-mutant Melanoma
|
1F30CA228388-01
|
$49,524
|
VITTORIA, MARC
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
DEFINING THE MEDULLOBLASTOMA CANCER STEM CELL LINEAGE HIERARCHY BY NOTCH SIGNALING
|
1F30CA228215-01
|
$40,238
|
HE, JOY
|
STANFORD UNIVERSITY
|
|
Defining the quantitative relationship between DNA damage and cell cycle dynamics in CUL9-deficient cells
|
5F30CA213876-02
|
$35,485
|
CHAO, HUI XIAO
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Defining the role of endometrial cancer PP2A A-alpha mutations in tumorigenesis
|
1F30CA224979-01A1
|
$44,524
|
TAYLOR, SARAH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining the role of mutant XPO1 in chronic lymphocytic leukemia
|
5F30CA196082-04
|
$49,524
|
HING, ZACHARY
|
OHIO STATE UNIVERSITY
|
|
Defining tolerance mechanisms regulating self-specific T cells
|
5F30CA217109-02
|
$49,524
|
LEE, VICTORIA
|
UNIVERSITY OF CHICAGO
|
|
Design and Delivery of Neoantigen-based Tumor Vaccines
|
1F30CA225136-01
|
$35,693
|
SMITH, CHRISTOF
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Designing Novel Anti-Cancer Therapeutics: Targeting Methionine Metabolism
|
5F30CA210372-02
|
$49,524
|
FIRESTONE, ROSS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Determining the Function of HMCES in DNA Replication and Repair
|
1F30CA228242-01
|
$29,204
|
THOMPSON, PETRIA
|
VANDERBILT UNIVERSITY
|
|
Determining the mechanism of aspartate sensing by the mTOR pathway
|
5F30CA210373-04
|
$49,524
|
OROZCO, JOSE
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Determining the Mechanisms of TWIST1-mediated Crizotinib Resistance in MET-driven Non-Small Cell Lung Carcinoma
|
5F30CA213765-02
|
$49,524
|
YOCHUM, ZACHARY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Development and Validation of a Predictive Model of Chemotherapy in Breast Cancer
|
5F30CA203220-03
|
$49,524
|
MCKENNA, MATTHEW
|
VANDERBILT UNIVERSITY
|
|
Development of a Multimodal Deep Learning Model for the Generation of Cancer Probability Maps and Imaging Biomarkers for Prostate Cancer using Multiparametric MRI
|
5F30CA210329-03
|
$38,022
|
SARMA, KARTHIK
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Development of a novel Antibody Drug Conjugate for the treatment of pancreaticcancer
|
1F30CA220843-01A1
|
$49,524
|
GROMISCH, CHRISTOPHER
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Development of covalent docking to identify new cysteine-targeted K-Ras inhibitors to address allelic variation in cancer
|
5F30CA214015-02
|
$36,028
|
NNADI, CHIMNO
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Discovering Vulnerabilities in Ras-driven Cancers
|
5F30CA203397-03
|
$48,315
|
NEILSEN, BETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Dissecting and targetting HDMX-medicated chemoresistance in human cancer
|
5F30CA221087-02
|
$36,202
|
MORGAN, ANN
|
DANA-FARBER CANCER INST
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|